RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity.

RKIP T cells autoimmunity cancer immunosuppression immunotherapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
13 Dec 2021
Historique:
received: 02 11 2021
revised: 06 12 2021
accepted: 06 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 25 12 2021
Statut: epublish

Résumé

Several gene products play pivotal roles in the induction of inflammation and the progression of cancer. The Raf kinase inhibitory protein (RKIP) is a cytosolic protein that exerts pleiotropic activities in such conditions, and thus regulates oncogenesis and immune-mediated diseases through its deregulation. Herein, we review the general properties of RKIP, including its: (i) molecular structure; (ii) involvement in various cell signaling pathways (i.e., inhibition of the Raf/MEK/ERK pathway; the NF-kB pathway; GRK-2 or the STAT-3 pathway; as well as regulation of the GSK3Beta signaling; and the spindle checkpoints); (iii) regulation of RKIP expression; (iv) expression's effects on oncogenesis; (v) role in the regulation of the immune system to diseases (i.e., RKIP regulation of T cell functions; the secretion of cytokines and immune mediators, apoptosis, immune check point inhibitors and RKIP involvement in inflammatory diseases); and (vi) bioinformatic analysis between normal and malignant tissues, as well as across various immune-related cells. Overall, the regulation of RKIP in different cancers and inflammatory diseases suggest that it can be used as a potential therapeutic target in the treatment of these diseases.

Identifiants

pubmed: 34944867
pii: cancers13246247
doi: 10.3390/cancers13246247
pmc: PMC8699197
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Chem Biol. 2005 Sep;12(9):981-91
pubmed: 16183022
J Immunol. 2006 Apr 15;176(8):4923-30
pubmed: 16585588
Immunology. 2014 Sep;143(1):42-51
pubmed: 24655025
Cancer Res. 2004 Aug 1;64(15):5186-92
pubmed: 15289323
Mol Cancer Res. 2009 Jun;7(6):832-40
pubmed: 19531568
Oncotarget. 2016 Apr 26;7(17):23512-20
pubmed: 26992205
PLoS One. 2012;7(5):e37819
pubmed: 22662230
Nat Commun. 2017 Dec 14;8(1):2125
pubmed: 29242551
EMBO J. 2017 May 2;36(9):1243-1260
pubmed: 28320739
Mol Cancer Ther. 2007 Apr;6(4):1387-99
pubmed: 17431117
Tumour Biol. 2012 Aug;33(4):919-25
pubmed: 22246605
Oncogene. 2008 Apr 3;27(15):2243-8
pubmed: 17952120
Crit Rev Oncog. 2014;19(6):431-45
pubmed: 25597353
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7865-70
pubmed: 22550173
Cancer Res. 2016 Jun 15;76(12):3644-54
pubmed: 27197200
Am Surg. 2012 Jan;78(1):1-8
pubmed: 22273282
Methods Mol Biol. 2010;661:497-505
pubmed: 20812004
Curr Biol. 1997 May 1;7(5):294-300
pubmed: 9115393
N Engl J Med. 2017 Aug 31;377(9):862-872
pubmed: 28854095
PLoS One. 2013 Dec 26;8(12):e83097
pubmed: 24386147
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12792-6
pubmed: 9371754
Int J Clin Exp Med. 2015 Dec 15;8(12):22183-90
pubmed: 26885193
Cancer Res. 2000 Dec 1;60(23):6630-40
pubmed: 11118046
Cancer Invest. 2012 Dec;30(10):703-11
pubmed: 23066640
PLoS One. 2017 May 19;12(5):e0177843
pubmed: 28542387
Mol Cell Biol. 2001 Nov;21(21):7207-17
pubmed: 11585904
Proteomics. 2010 Aug;10(15):2812-21
pubmed: 20533335
Cancer Res. 2016 Jan 15;76(2):275-82
pubmed: 26567139
Nat Rev Cancer. 2007 Jun;7(6):415-28
pubmed: 17508028
Cell Cycle. 2005 Feb;4(2):217-20
pubmed: 15655344
Front Immunol. 2020 Oct 06;11:593203
pubmed: 33117406
Mol Cell Biol. 2005 Jul;25(13):5404-16
pubmed: 15964798
Mol Cell Biol. 2007 Jun;27(12):4374-87
pubmed: 17438126
Oncol Rep. 2006 Sep;16(3):451-6
pubmed: 16865242
J Biol Chem. 2003 Apr 11;278(15):13061-8
pubmed: 12551925
FEBS Lett. 2006 Nov 27;580(27):6405-12
pubmed: 17097642
Genes Dev. 1996 Nov 1;10(21):2684-95
pubmed: 8946910
Redox Biol. 2015 Dec;6:486-494
pubmed: 26432660
Mol Cancer Res. 2009 Feb;7(2):221-9
pubmed: 19208738
Pathology. 2012 Oct;44(6):534-9
pubmed: 22935977
Cancer Surv. 1996;27:101-25
pubmed: 8909797
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11606-11
pubmed: 14500907
Mol Biol (Mosk). 2011 Nov-Dec;45(6):1004-11
pubmed: 22295570
Am J Transl Res. 2017 May 15;9(5):2181-2194
pubmed: 28559970
Science. 1998 Sep 11;281(5383):1671-4
pubmed: 9733513
Oxid Med Cell Longev. 2018 Oct 2;2018:1347969
pubmed: 30370001
Oncotarget. 2017 Jun 20;8(25):40412-40424
pubmed: 28418894
Exp Dermatol. 2009 Jun;18(6):571-3
pubmed: 19228192
Diabetologia. 2003 Apr;46(4):524-30
pubmed: 12739026
Eur Urol. 2014 Jun;65(6):1140-51
pubmed: 24373479
Mol Cell Biol. 2009 Mar;29(5):1306-20
pubmed: 19103740
Cancer Res. 2004 Oct 1;64(19):7117-26
pubmed: 15466208
Cell. 2019 Jul 11;178(2):316-329.e18
pubmed: 31257023
J Exp Clin Cancer Res. 2017 May 5;36(1):62
pubmed: 28476134
Trends Cell Biol. 2001 Feb;11(2):49-54
pubmed: 11166196
Nature. 2012 Dec 6;492(7427):108-12
pubmed: 23051747
Cell Rep. 2017 Jul 25;20(4):854-867
pubmed: 28746871
Cell Physiol Biochem. 2012;30(6):1340-50
pubmed: 23095933
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13453-13458
pubmed: 29208709
BMC Cancer. 2011 Jun 21;11:259
pubmed: 21689459
Lancet. 1978 Nov 25;2(8100):1116-8
pubmed: 82681
Front Immunol. 2018 Jan 22;9:14
pubmed: 29403496
Clin Rev Allergy Immunol. 2005 Jun;28(3):187-96
pubmed: 16129903
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):232-5
pubmed: 1729694
Nat Rev Mol Cell Biol. 2002 Mar;3(3):155-66
pubmed: 11994736
Nat Rev Cancer. 2012 Jan 24;12(2):89-103
pubmed: 22270953
Drug Resist Updat. 2019 Mar;43:10-28
pubmed: 31005030
Biochem J. 1994 Jul 1;301 ( Pt 1):235-42
pubmed: 8037677
N Engl J Med. 2003 Jan 9;348(2):138-50
pubmed: 12519925
Crit Rev Biochem Mol Biol. 2014 Jan-Feb;49(1):16-32
pubmed: 24164576
Mol Cancer. 2014 Aug 16;13:193
pubmed: 25128483
Gene. 1994 Mar 25;140(2):293-4
pubmed: 8144042
Oncogene. 1999 Nov 22;18(49):6853-66
pubmed: 10602461
Mol Biosyst. 2011 Mar;7(3):928-41
pubmed: 21180766
J Cell Biol. 1999 May 17;145(4):837-49
pubmed: 10330410
Cell. 1995 Dec 15;83(6):831-4
pubmed: 8521506
J Hematol Oncol. 2020 Jul 28;13(1):104
pubmed: 32723346
Mol Cancer Ther. 2012 Mar;11(3):572-81
pubmed: 22267549
Genes Dev. 2007 May 15;21(10):1179-89
pubmed: 17504937
Bioorg Med Chem Lett. 2015 Sep 1;25(17):3644-9
pubmed: 26189078
BMC Cancer. 2013 Oct 08;13:463
pubmed: 24098947
EMBO Rep. 2018 Jun;19(6):
pubmed: 29674348
Endocr Rev. 2015 Feb;36(1):25-64
pubmed: 25426780
Cell. 2011 Oct 14;147(2):358-69
pubmed: 22000014
Eur J Biochem. 2001 Nov;268(22):5831-41
pubmed: 11722570
Surgery. 2004 Sep;136(3):708-15
pubmed: 15349122
Nature. 2003 Dec 4;426(6966):574-9
pubmed: 14654844
J Clin Oncol. 2006 Dec 20;24(36):5672-9
pubmed: 17179102
Cancer Res. 2012 Jun 15;72(12):3091-104
pubmed: 22505648
Oncol Lett. 2015 Dec;10(6):3807-3815
pubmed: 26788213
PLoS One. 2012;7(1):e30769
pubmed: 22292035
Acta Histochem. 2013 Oct;115(8):795-802
pubmed: 23601922
Med Oncol. 2010 Jun;27(2):219-23
pubmed: 19291429
Oncotarget. 2017 Oct 10;8(55):94358-94370
pubmed: 29212233
Mutat Res. 2008 Dec 1;647(1-2):21-9
pubmed: 18723033
Nat Rev Immunol. 2005 Oct;5(10):749-59
pubmed: 16175180
Curr Opin Cell Biol. 1997 Apr;9(2):180-6
pubmed: 9069255
J Clin Invest. 2011 Jun;121(6):2350-60
pubmed: 21555851
Immunity. 2017 Apr 18;46(4):596-608
pubmed: 28410989
Cancers (Basel). 2018 Aug 24;10(9):
pubmed: 30149591
Nat Cell Biol. 2004 Feb;6(2):146-53
pubmed: 14743220
Cancer Res. 2009 Nov 1;69(21):8376-85
pubmed: 19843864
Oncogene. 2015 Sep 24;34(39):5003-11
pubmed: 25619839
Cell Cycle. 2011 Aug 15;10(16):2792-805
pubmed: 21822052
Science. 2008 May 2;320(5876):667-70
pubmed: 18451303
Cancer Res. 2009 Jan 1;69(1):329-37
pubmed: 19118018
Cancer Res. 2005 Jan 1;65(1):195-202
pubmed: 15665295
Cancer Microenviron. 2014 Dec;7(3):117-31
pubmed: 24938990
Proteomics. 2009 Jan;9(1):205-9
pubmed: 19053139
Front Immunol. 2014 Feb 10;5:45
pubmed: 24575094
Cell Cycle. 2010 Dec 15;9(24):4931-40
pubmed: 21150329
Cell. 2007 Jun 29;129(7):1311-23
pubmed: 17604720
Nitric Oxide. 2013 Feb 28;29:17-24
pubmed: 23246440
iScience. 2018 Apr 27;2:105-122
pubmed: 30428369
Clin Immunol Immunopathol. 1991 Aug;60(2):220-31
pubmed: 2070568
Annu Rev Immunol. 2009;27:693-733
pubmed: 19302050
Nat Rev Mol Cell Biol. 2005 Nov;6(11):827-37
pubmed: 16227978
Nat Rev Immunol. 2015 Jan;15(1):45-56
pubmed: 25534622
Biochim Biophys Acta. 1984 Oct 23;790(2):174-81
pubmed: 6435678
J Med Chem. 2018 Feb 8;61(3):650-665
pubmed: 29211475
J Cell Physiol. 2021 May;236(5):3963-3978
pubmed: 33151569
Cancer Lett. 2006 Nov 28;244(1):76-8
pubmed: 16442710
J Neurochem. 1988 Apr;50(4):1210-4
pubmed: 3279164
PLoS One. 2014 Mar 21;9(3):e92478
pubmed: 24658061
Nat Rev Cancer. 2009 Nov;9(11):773-84
pubmed: 19851313
Nat Rev Cancer. 2002 Apr;2(4):301-10
pubmed: 12001991
J Cell Biochem. 2019 Apr;120(4):6168-6177
pubmed: 30304566
J Immunol. 2007 Oct 15;179(8):5441-53
pubmed: 17911631
Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 Pt 2):1077-80
pubmed: 12037323
J Biol Chem. 2004 Apr 23;279(17):17515-23
pubmed: 14766752
Int J Oncol. 2013 Jan;42(1):349-58
pubmed: 23135610
Science. 1998 Sep 11;281(5383):1625-6
pubmed: 9767029
Structure. 1998 Oct 15;6(10):1245-54
pubmed: 9782050
J Mol Evol. 1994 Dec;39(6):655-60
pubmed: 7807553
Nature. 2006 Sep 21;443(7109):350-4
pubmed: 16921384
JAMA. 1992 Dec 23-30;268(24):3452-5
pubmed: 1460735
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7922-7
pubmed: 23620515
Nitric Oxide. 2011 Jan 1;24(1):1-7
pubmed: 20933602
Cancer Lett. 2010 Dec 28;299(2):137-49
pubmed: 20855151
J Immunol. 1993 May 1;150(9):3785-92
pubmed: 8473733
Clin Immunol. 2006 Sep;120(3):297-309
pubmed: 16784892
J Exp Med. 1992 Feb 1;175(2):387-96
pubmed: 1370682
For Immunopathol Dis Therap. 2013;4(1):
pubmed: 24187651
Oxid Med Cell Longev. 2019 Jul 14;2019:9372182
pubmed: 31396308
Prostate. 2006 Feb 15;66(3):248-56
pubmed: 16175585
EMBO J. 2009 Feb 18;28(4):347-58
pubmed: 19153603
Cell Cycle. 2009 May 1;8(9):1367-72
pubmed: 19342874
For Immunopathol Dis Therap. 2011 Apr 1;2(2):
pubmed: 24286018
Gynecol Oncol. 1999 May;73(2):257-64
pubmed: 10329044
Crit Rev Oncog. 2014;19(6):497-504
pubmed: 25597359
Clin Cancer Res. 2007 Oct 1;13(19):5665-9
pubmed: 17908954
Oncogene. 2005 Dec 8;24(55):8114-27
pubmed: 16103877
Eur J Immunol. 1997 Jun;27(6):1442-50
pubmed: 9209497
Int J Oncol. 2009 Dec;35(6):1289-96
pubmed: 19885551
Nature. 2008 Sep 4;455(7209):58-63
pubmed: 18668040
Front Pharmacol. 2014 Apr 08;5:61
pubmed: 24782769
Mol Cell. 2006 Aug;23(4):561-74
pubmed: 16916643
Biochem Biophys Res Commun. 2012 Aug 24;425(2):127-33
pubmed: 22809510
Int J Oncol. 2014 Sep;45(3):1184-92
pubmed: 24970600
Nature. 2015 Nov 12;527(7577):249-53
pubmed: 26503055
Clin Cancer Res. 2002 Apr;8(4):945-54
pubmed: 11948098
Am J Physiol Cell Physiol. 2014 Dec 1;307(11):C1010-6
pubmed: 25231108
Nature. 2001 Mar 1;410(6824):37-40
pubmed: 11242034
Nat Rev Cancer. 2002 Jun;2(6):442-54
pubmed: 12189386
PLoS One. 2012;7(1):e29532
pubmed: 22279539
For Immunopathol Dis Therap. 2011;2(1):47-58
pubmed: 21709760
J Exp Clin Cancer Res. 2012 Mar 31;31:30
pubmed: 22463874
PLoS One. 2012;7(4):e36187
pubmed: 22558375
Radiat Oncol. 2016 Sep 20;11(1):121
pubmed: 27647315
Int J Oncol. 2011 Jun;38(6):1683-94
pubmed: 21455568
Gut. 2006 Oct;55(10):1467-74
pubmed: 16469793
Cancers (Basel). 2018 Sep 04;10(9):
pubmed: 30181452
J Immunol. 2000 Feb 15;164(4):1807-13
pubmed: 10657628
PLoS One. 2009 Jun 24;4(6):e6028
pubmed: 19551145
Hum Pathol. 1998 Apr;29(4):421-4
pubmed: 9563797
Biochem Biophys Res Commun. 2006 Apr 21;342(4):1083-7
pubmed: 16513087
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Oncogene. 2007 May 28;26(25):3629-36
pubmed: 17530016
J Biol Chem. 1998 Mar 27;273(13):7743-8
pubmed: 9516483
Oncotarget. 2015 Feb 28;6(6):3904-17
pubmed: 25714010
Cancer Res. 2011 Oct 15;71(20):6503-13
pubmed: 21868758
J Immunol. 2013 Jul 15;191(2):708-16
pubmed: 23761631
J Immunol. 2009 Dec 1;183(11):7489-96
pubmed: 19917702
Clin Cancer Res. 2008 May 15;14(10):2994-3001
pubmed: 18483365
Leuk Lymphoma. 2018 Dec;59(12):2917-2928
pubmed: 29911936
Int J Cancer. 2018 Jun 1;142(11):2323-2334
pubmed: 29315556
Curr Opin Cell Biol. 1997 Apr;9(2):174-9
pubmed: 9069260
Curr Biol. 1998 Jan 1;8(1):56-64
pubmed: 9427629
Annu Rev Immunol. 2002;20:761-94
pubmed: 11861617
Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):467-474
pubmed: 26894644
Cancer. 2011 Jun 1;117(11):2499-504
pubmed: 24048798
Leuk Lymphoma. 2011 Jan;52(1):108-21
pubmed: 21133714
Science. 2005 Oct 14;310(5746):306-10
pubmed: 16224021
Biochim Biophys Acta. 1997 Apr 18;1332(2):F49-66
pubmed: 9141463
Oncotarget. 2017 Jun 27;8(40):67439-67456
pubmed: 28978044
Acta Pharm Sin B. 2018 Jul;8(4):552-562
pubmed: 30109180
Immunity. 2016 May 17;44(5):989-1004
pubmed: 27192565
Annu Rev Immunol. 1989;7:445-80
pubmed: 2653373
Mol Cell Biol. 2000 May;20(9):3079-85
pubmed: 10757792
Oncol Lett. 2017 Mar;13(3):1866-1872
pubmed: 28454336
Curr Protein Pept Sci. 2015;16(4):279-94
pubmed: 25929862
Genet Mol Res. 2015 Dec 09;14(4):16491-6
pubmed: 26662448
Drug Resist Updat. 2017 Jan;30:28-38
pubmed: 28363333
Mol Cell Biol. 1996 Nov;16(11):6083-95
pubmed: 8887638
Cancer Cell Int. 2019 Mar 29;19:74
pubmed: 30976198
Cell Death Differ. 2017 Jan;24(1):59-71
pubmed: 27716745
Crit Rev Oncog. 2014;19(6):483-8
pubmed: 25597357
J Natl Cancer Inst. 2003 Jun 18;95(12):878-89
pubmed: 12813171
Int J Mol Sci. 2019 Nov 16;20(22):
pubmed: 31744053
Sci Adv. 2020 Apr 22;6(17):eaaw8500
pubmed: 32494626
Mol Endocrinol. 1990 Sep;4(9):1370-6
pubmed: 1978248
Neoplasma. 2018;65(2):228-233
pubmed: 29534584
Clin Cancer Res. 2005 Oct 15;11(20):7392-7
pubmed: 16243812
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):E364-73
pubmed: 24395801
Biomolecules. 2019 Nov 22;9(12):
pubmed: 31766768
Mol Cell Biol. 2013 Aug;33(16):3274-85
pubmed: 23775117
J Exp Med. 1998 Jul 20;188(2):277-86
pubmed: 9670040
Nat Rev Immunol. 2011 Aug 26;11(10):645-57
pubmed: 21869816
Cancer Res. 2012 Dec 1;72(23):6217-26
pubmed: 23066033
Genes Dev. 2004 Nov 1;18(21):2596-601
pubmed: 15520279
Science. 1993 Jun 11;260(5114):1658-61
pubmed: 8503013
Crit Rev Oncog. 2018;23(5-6):281-305
pubmed: 30311561
J Cell Physiol. 2013 Aug;228(8):1688-702
pubmed: 23359513
Structure. 1998 Oct 15;6(10):1255-65
pubmed: 9782057
Cell Signal. 2008 May;20(5):935-41
pubmed: 18294816
J Biol Chem. 2003 Mar 7;278(10):8135-45
pubmed: 12506115
Nature. 2001 Jan 11;409(6817):207-11
pubmed: 11196646
PLoS One. 2010 May 05;5(5):e10479
pubmed: 20463977
Nitric Oxide. 2008 Sep;19(2):152-7
pubmed: 18477483
PLoS One. 2016 Mar 04;11(3):e0149370
pubmed: 26943330
Tumour Biol. 2014 Oct;35(10):10095-103
pubmed: 25017365
J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):118-24
pubmed: 20980914
Cancer Res. 2011 Feb 15;71(4):1334-43
pubmed: 21303975
Adv Cancer Res. 2004;91:169-200
pubmed: 15327891
J Clin Endocrinol Metab. 2014 Nov;99(11):E2178-87
pubmed: 25078145
Crit Rev Oncog. 2014;19(6):469-81
pubmed: 25597356
J Clin Invest. 2018 Aug 31;128(9):3813-3818
pubmed: 29905573
Science. 2005 Jan 14;307(5707):269-73
pubmed: 15653507
Clin Exp Metastasis. 2013 Mar;30(3):265-75
pubmed: 22983529
Am J Cancer Res. 2013 Nov 01;3(5):446-64
pubmed: 24224123
Nitric Oxide. 2009 Feb;20(1):39-52
pubmed: 18778787
Cell Mol Immunol. 2021 Apr;18(4):992-1004
pubmed: 32901127
Cell Mol Immunol. 2005 Jun;2(3):197-203
pubmed: 16212887
Crit Rev Immunol. 2010;30(1):31-46
pubmed: 20370618
Curr Top Dev Biol. 1996;33:1-60
pubmed: 9138904
Gastroenterology. 2006 Oct;131(4):1208-17
pubmed: 17030190
Acta Pharmacol Sin. 2018 Feb;39(2):302-310
pubmed: 28858300
Cancer Metastasis Rev. 2012 Dec;31(3-4):615-20
pubmed: 22684368
Genes Dev. 2015 Mar 15;29(6):567-84
pubmed: 25792595
Cell Physiol Biochem. 2017;41(3):1135-1146
pubmed: 28245474
Int J Oncol. 2007 Oct;31(4):685-91
pubmed: 17786298
OMICS. 2012 Nov;16(11):579-88
pubmed: 23095110
J Biol Chem. 2012 Jul 6;287(28):23407-17
pubmed: 22610096
Cell Rep. 2018 Jun 12;23(11):3262-3274
pubmed: 29898397
Oncogene. 2006 Feb 23;25(8):1125-42
pubmed: 16314846
J Immunol. 2001 Jul 1;167(1):75-81
pubmed: 11418634
J Clin Pathol. 2008 Apr;61(4):524-9
pubmed: 18375747
Nature. 1999 Sep 9;401(6749):173-7
pubmed: 10490027
Curr Biol. 1998 Jan 1;8(1):46-55
pubmed: 9427625
Int J Mol Sci. 2015 Jun 11;16(6):13322-38
pubmed: 26110379
Nat Rev Cancer. 2007 Oct;7(10):778-90
pubmed: 17882278
Free Radic Biol Med. 2021 Feb 1;163:69-87
pubmed: 33307168
J Infect Dis. 2013 Jul;208(1):50-6
pubmed: 23089590

Auteurs

Roni Touboul (R)

Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, CA 90095, USA.

Stavroula Baritaki (S)

Laboratory of Experimental Oncology, Division of Surgery, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece.

Apostolos Zaravinos (A)

Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia 2404, Cyprus.
Basic and Translational Cancer Research Center (BTCRC), Cancer Genetics, Genomics and Systems Biology Laboratory, Nicosia 1516, Cyprus.

Benjamin Bonavida (B)

Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, CA 90095, USA.

Classifications MeSH